Angola vs Rwanda: HIV/AIDS deaths averted by antiretroviral therapy
Angola
14,494 deaths
in 2024
Rwanda
13,299 deaths
in 2024
Angola rank
16th
Rwanda rank
18th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Angola
- Rwanda
How they compare
Angola currently reports 14,494 deaths against 13,299 deaths in Rwanda, a difference of 1,195 deaths.
That makes Angola's figure about 1.1 times Rwanda's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Rwanda ahead.
Angola ranks 16th and Rwanda ranks 18th of 157 countries.
Rwanda has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Angola | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 765.87 deaths | 3,990 deaths | 3,224 deaths | Rwanda |
| 2010s | 7,024 deaths | 12,999 deaths | 5,975 deaths | Rwanda |
| 2020s | 12,363 deaths | 13,654 deaths | 1,292 deaths | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Angola or Rwanda?
- Angola, at 14,494 deaths against 13,299 deaths in Rwanda as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Angola and Rwanda?
- 1,195 deaths, with Angola ahead.
- How many years of comparable data are there for Angola and Rwanda?
- 35 years are reported by both, from 1990 to 2024.
- How do Angola and Rwanda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Angola ranks 16th and Rwanda ranks 18th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.